A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure

BACKGROUND AND OBJECTIVE: The blocking of aldosterone or angiotensin II receptors improves mortality in patients with chronic heart failure. We explored whether combining losartan and spironolactone would have any added benefit on the known surrogate of mortality by using heart rate variability (HRV...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehab, A, Elnour, AA, Struthers, AD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2008
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971616/
https://www.ncbi.nlm.nih.gov/pubmed/19104723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971616/
https://www.ncbi.nlm.nih.gov/pubmed/19104723

Ejemplares similares